Discover the full record of transactions filed by Sachdev Amit, 董事. Insider active across 3 companies, notably Vertex Pharmaceuticals INC / MA. Aggregated, 38 filings have been published. Split: 0 buy · 10 sells. Total volume traded: €4.5m. Activity tracked since 17 May 2021. The latest transaction was disclosed on 21 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sachdev Amit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Sachdev Amit is Executive Director, Chief Patient and Ext Af Off, and a director at Vertex Pharmaceuticals INC / MA, VERTEX PHARMACEUTICALS INC / MA, and a director at Eiger BioPharmaceuticals, Inc. He has 37 filings in total. Across the 37 sampled filings, the period runs from 2016-02-04 to 2026-02-26, with 0 EUR of buys and 4471086 EUR of sells, and the most frequent transaction nature is tax withholding.